Home » Topics » Regulatory » Patents

Patents
RSS

NEP/ACE/ECE inhibitors described by Wakamoto

June 4, 1997

U. of California discloses mammalian EPO-BP

June 4, 1997

Anti E- and P-selectin antibodies from PDL

June 4, 1997

Tanabe Seiyaku reveals new ET antagonists

June 3, 1997

Nippon Kayaku discovers new antitumor agent

June 3, 1997

Orally active antiplatelet agents described by Taisho

June 3, 1997

Lilly prepares new 5-HT1F agonists

June 3, 1997

Suntory presents new glutamate receptor antagonists

June 3, 1997

AGE inhibitor described by Kissei

June 3, 1997

CAAX-based protein farnesyltransferase inhibitors from Merck & Co.

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...